Table_4.xls (5.5 kB)
One-year cumulative risk of infection among the patients with cetuximab and those without (n = 1083)a.
dataset
posted on 2013-02-19, 19:39 authored by Ching-Chih Lee, Hsu-Chueh Ho, Shih-Hsuan Hsiao, Tza-Ta Huang, Hon-Yi Lin, Szu-Chin Li, Pesus Chou, Yu-Chieh Sua
Stratum 1 had the strongest propensity for not receiving cetuximab therapy; stratum 5, for receiving cetuximab therapy.
bCochran-Mantel-Haenszel statistics; adjusted odds ratio = 2.27, 95% confidence interval = 1.46–3.54.